• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
COVID-19 convalescent plasma therapy: hit fast, hit hard!新冠康复者血浆疗法：速战速决，重拳出击！
Vox Sang. 2021 Oct;116(9):935-942. doi: 10.1111/vox.13091. Epub 2021 Apr 1.
2
Convalescent plasma for COVID-19 considerations.关于新冠病毒病恢复期血浆的考量
Transfus Apher Sci. 2021 Feb;60(1):102927. doi: 10.1016/j.transci.2020.102927. Epub 2020 Aug 27.
3
Covid-19 convalescent plasma and SARS-CoV-2 viral variants.新冠康复者血浆与严重急性呼吸综合征冠状病毒2病毒变体
Transfus Clin Biol. 2021 Aug;28(3):306. doi: 10.1016/j.tracli.2021.05.008. Epub 2021 May 29.
4
COVID-19 convalescent plasma therapy and immunodeficiency.新冠康复者血浆疗法与免疫缺陷
Transfus Clin Biol. 2021 Aug;28(3):306-307. doi: 10.1016/j.tracli.2021.05.007. Epub 2021 May 29.
5
[Convalescent plasma therapy in COVID-19 patients].[新冠病毒肺炎患者的恢复期血浆治疗]
Medicina (B Aires). 2021;81(2):306.
6
Use of Convalescent Plasma in the Management of COVID-19.康复期血浆在新型冠状病毒肺炎治疗中的应用
Mo Med. 2021 Mar-Apr;118(2):118.
7
Implications of Coronavirus Disease 2019 (COVID-19) Antibody Dynamics for Immunity and Convalescent Plasma Therapy.2019年冠状病毒病（COVID-19）抗体动力学对免疫及恢复期血浆治疗的影响
Clin Infect Dis. 2021 Aug 2;73(3):e540-e542. doi: 10.1093/cid/ciaa1213.
8
How Safe Is COVID-19 Convalescent Plasma?新冠康复者血浆有多安全？
Mayo Clin Proc. 2021 Aug;96(8):2279-2281. doi: 10.1016/j.mayocp.2021.06.011. Epub 2021 Jun 25.
9
Correspondence on 'CONVALESCENT plasma for COVID-19'.关于“COVID-19康复期血浆治疗”的通信
Eur J Clin Invest. 2021 Nov;51(11):e13677. doi: 10.1111/eci.13677. Epub 2021 Sep 13.
10
[COVID-19: blood sufficiency versus convalescent plasma?].[新冠病毒肺炎：血液充足疗法与康复期血浆疗法？]
Rev Med Chil. 2020 Jun;148(6):721-723. doi: 10.4067/S0034-98872020000600721.

引用本文的文献

1
Exploring Study Design Foibles in Randomized Controlled Trials on Convalescent Plasma in Hospitalized COVID-19 Patients.探索住院COVID-19患者恢复期血浆随机对照试验中的研究设计缺陷
Life (Basel). 2024 Jun 22;14(7):792. doi: 10.3390/life14070792.
2
Vaccine-Boosted CCP Decreases Virus Replication and Hastens Resolution of Infection Despite Transiently Enhancing Disease in SARS-CoV-2-Infected Hamsters.疫苗增强的新冠病毒复制减少并加速感染清除，尽管在感染 SARS-CoV-2 的仓鼠中短暂增强了疾病。
J Infect Dis. 2024 Jun 14;229(6):1702-1710. doi: 10.1093/infdis/jiad568.
3
Passive antibody therapy in emerging infectious diseases.新发传染病中的被动抗体疗法。
Front Med. 2023 Dec;17(6):1117-1134. doi: 10.1007/s11684-023-1021-y. Epub 2023 Dec 2.
4
COVID-19: Variants, Immunity, and Therapeutics for Non-Hospitalized Patients.COVID-19：非住院患者的变体、免疫与治疗方法
Biomedicines. 2023 Jul 21;11(7):2055. doi: 10.3390/biomedicines11072055.
5
An update on SARS-CoV-2 immunization and future directions.新型冠状病毒2型免疫接种的最新情况及未来方向。
Front Pharmacol. 2023 Mar 9;14:1125305. doi: 10.3389/fphar.2023.1125305. eCollection 2023.
6
COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis.COVID-19 恢复期血浆治疗免疫功能低下患者：系统评价和荟萃分析。
JAMA Netw Open. 2023 Jan 3;6(1):e2250647. doi: 10.1001/jamanetworkopen.2022.50647.
7
Home and Out-of-Hospital Therapy with COVID-19 Convalescent Plasma in Europe.欧洲使用新冠康复期血浆进行居家及院外治疗
Life (Basel). 2022 Oct 26;12(11):1704. doi: 10.3390/life12111704.
8
An Exploratory Study of the Differences in Attitudes and Motives Regarding COVID-19 Plasma Donation.关于新冠病毒康复者血浆捐献的态度和动机差异的探索性研究。
Acta Med Litu. 2022;29(1):69-77. doi: 10.15388/Amed.2022.29.1.14. Epub 2022 Jul 26.
9
Influence of SARS-CoV-2 inactivation by different chemical reagents on the humoral response evaluated in a murine model.不同化学试剂对 SARS-CoV-2 灭活作用对小鼠模型体液免疫反应评估的影响。
Mol Immunol. 2022 Jul;147:199-208. doi: 10.1016/j.molimm.2022.05.012. Epub 2022 May 23.
10
Modified Hemagglutination Tests for COVID-19 Serology in Resource-Poor Settings: Ready for Prime-Time?资源匮乏地区用于新冠病毒血清学检测的改良血凝试验：准备好进入黄金时段了吗？
Vaccines (Basel). 2022 Mar 8;10(3):406. doi: 10.3390/vaccines10030406.

本文引用的文献

1
Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 disease.新冠重症患者恢复期血浆治疗对比标准治疗的随机对照试验
Sci Rep. 2021 May 11;11(1):9927. doi: 10.1038/s41598-021-89444-5.
2
Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial.早期与延迟使用抗 SARS-CoV-2 恢复期血浆治疗因 COVID-19 住院患者：一项随机 II 期临床试验。
PLoS Med. 2021 Mar 3;18(3):e1003415. doi: 10.1371/journal.pmed.1003415. eCollection 2021 Mar.
3
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19.恢复期血浆抗体水平与新冠死亡风险。
N Engl J Med. 2021 Mar 18;384(11):1015-1027. doi: 10.1056/NEJMoa2031893. Epub 2021 Jan 13.
4
Early mortality benefit with COVID-19 convalescent plasma: a matched control study.COVID-19 恢复期血浆的早期死亡获益：一项匹配对照研究。
Br J Haematol. 2021 Feb;192(4):706-713. doi: 10.1111/bjh.17272. Epub 2021 Jan 22.
5
Treatment of severe COVID-19 with convalescent plasma in Bronx, NYC.纽约市布朗克斯区使用恢复期血浆治疗重症 COVID-19。
JCI Insight. 2021 Feb 22;6(4):142270. doi: 10.1172/jci.insight.142270.
6
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults.早期高滴度血浆疗法预防老年人重症 COVID-19。
N Engl J Med. 2021 Feb 18;384(7):610-618. doi: 10.1056/NEJMoa2033700. Epub 2021 Jan 6.
7
Clinical efficacy of convalescent plasma therapy on treating COVID-19 patients: Evidence from matched study and a meta-analysis.恢复期血浆疗法治疗新冠肺炎患者的临床疗效：来自配对研究和荟萃分析的证据。
Clin Transl Med. 2020 Dec;10(8):e259. doi: 10.1002/ctm2.259.
8
Viral infection neutralization tests: A focus on severe acute respiratory syndrome-coronavirus-2 with implications for convalescent plasma therapy.病毒感染中和试验：聚焦严重急性呼吸综合征冠状病毒2及其对恢复期血浆治疗的意义
Rev Med Virol. 2021 Mar;31(2):e2170. doi: 10.1002/rmv.2170. Epub 2020 Sep 21.
9
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia.新冠肺炎重症肺炎患者恢复期血浆的随机临床试验。
N Engl J Med. 2021 Feb 18;384(7):619-629. doi: 10.1056/NEJMoa2031304. Epub 2020 Nov 24.
10
A retrospective study assessing the characteristics of COVID-19 convalescent plasma donors and donations.一项回顾性研究评估了 COVID-19 恢复期血浆供者和捐赠的特征。
Transfusion. 2021 Mar;61(3):830-838. doi: 10.1111/trf.16208. Epub 2020 Dec 14.

COVID-19 convalescent plasma therapy: hit fast, hit hard!

作者信息

Focosi Daniele, Franchini Massimo

机构信息

North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy.

Department of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantua, Italy.

出版信息

Vox Sang. 2021 Oct;116(9):935-942. doi: 10.1111/vox.13091. Epub 2021 Apr 1.

DOI:10.1111/vox.13091
PMID:33794556
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8251446/
Abstract
摘要